Cargando…
Developing Models to Predict BRAFV600E and RAS Mutational Status in Papillary Thyroid Carcinoma Using Clinicopathological Features and pERK1/2 Immunohistochemistry Expression
The Cancer Genome Atlas (TCGA) has classified papillary thyroid carcinoma (PTC) into indolent RAS-like and aggressive BRAF-like based on its distinct driver gene mutations. This retrospective study aimed to assess clinicopathology and pERK1/2 expression variations between BRAF-like and RAS-like PTCs...
Autores principales: | Harahap, Agnes Stephanie, Subekti, Imam, Panigoro, Sonar Soni, Asmarinah, Lisnawati, Werdhani, Retno Asti, Agustina, Hasrayati, Khoirunnisa, Dina, Mutmainnah, Mutiah, Gultom, Fajar Lamhot, Assadyk, Abdillah Hasbi, Ham, Maria Francisca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603905/ https://www.ncbi.nlm.nih.gov/pubmed/37893176 http://dx.doi.org/10.3390/biomedicines11102803 |
Ejemplares similares
-
Profile of BRAFV600E, BRAFK601E, NRAS, HRAS, and KRAS Mutational Status, and Clinicopathological Characteristics of Papillary Thyroid Carcinoma in Indonesian National Referral Hospital
por: Harahap, Agnes Stephanie, et al.
Publicado: (2023) -
Medical problem in Asia pacific and ways to solve it: The roles of primary care/family physician (Indonesia Xperience)
por: Werdhani, Retno Asti
Publicado: (2019) -
Sistrunk Procedure on Malignant Thyroglossal Duct Cyst
por: Kartini, Diani, et al.
Publicado: (2020) -
Early upregulation of AR and steroidogenesis enzyme expression after 3 months of androgen-deprivation therapy
por: Hamid, Agus Rizal A. H., et al.
Publicado: (2020) -
Are we ready to collaborate? The interprofessional collaborative competencies of healthcare professionals in the Global South context
por: Soemantri, Diantha, et al.
Publicado: (2022)